Dr. McClellan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
265 Campus Dr
Room G3005
Stanford, CA 94305Phone+1 650-723-6661
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2008 - 2012- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2006 - 2009
Washington University in St. Louis School of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2007 - 2025
Publications & Presentations
PubMed
- 46 citationsPhase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myelomaA. Keith Stewart, Amrita Krishnan, Seema Singhal, Ralph V. Boccia, Manish R. Patel
Blood Cancer Journal. 2019-02-04 - 1 citationsReply to Fišer et al.: Myeloid reprogramming of Ph+ B-ALL: A potential therapeutic strategy.Ravindra Majeti, Christopher Dove, James Scott McClellan
Proceedings of the National Academy of Sciences of the United States of America. 2015-07-07 - 43 citationsReprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophagesJames Scott McClellan, Christopher Dove, Andrew J. Gentles, Christine E. Ryan, Ravindra Majeti
Proceedings of the National Academy of Sciences of the United States of America. 2015-03-31
Press Mentions
Group Reprograms B-ALL Cells into Macrophage-like CellsMarch 17th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
